Lipoprotein abnormalities in non-insulin-dependent diabetic patients with impaired extrahepatic insulin sensitivity, hypertension, and microalbuminuria.

We investigated whether specific lipoprotein abnormalities are present in non-insulin-dependent diabetes mellitus (NIDDM) patients with hypertension and/or microalbuminuria. Fifteen normotensive normoalbuminuric (H-M-), 32 hypertensive normoalbuminuric (H+M-), and 22 hypertensive microalbuminuric (H+M+) NIDDM patients and 20 sex-, age-, and weight-matched nondiabetic control subjects were studied. Lipoprotein size was measured by nondenaturing polyacrylamide gradient gel electrophoresis; insulin sensitivity was assessed by using a euglycemic hyperinsulinemic clamp and [6,6(2)H]glucose tracer infusion for simultaneous measurement of hepatic glucose output and whole-body glucose utilization. Total plasma and very-low-density lipoprotein cholesterol were higher in H+M+ than in control subjects (5.84 +/- 0.98 versus 4.97 +/- 0.98 and 0.57 +/- 0.54 versus 0.26 +/- 0.21 mmol/L, mean +/- SD, P < .05). Plasma triglycerides were higher in H+M+ than in either control or H-M- subjects (2.17 +/- 1.32 versus 1.18 +/- 0.67 and 1.30 +/- 0.59 mmol/L, respectively; P < .05). The mean low-density lipoprotein diameter was 27.2 +/- 0.8 in control, 26.7 +/- 0.8 in H-M-, 26.5 +/- 0.8 nm in H+M- (P < .05 versus control subjects), and 26.0 +/- 0.8 nm in H+M+ subjects (P < .05 versus control subjects). The mean cholesterol level of the large high-density lipoprotein particles was lower in H+M- and H+M+ (0.37 +/- 0.14 and 0.36 +/- 0.16 mmol/L) than in control and H-M- (0.54 +/- 0.41 and 0.54 +/- 0.27 mmol/L, P < .05) subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  R. Krauss,et al.  Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. , 1993, The Journal of clinical investigation.

[2]  A. Donker,et al.  Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus , 1992, The Lancet.

[3]  A. Hamsten,et al.  Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man , 1992, The Lancet.

[4]  F. Macdonald,et al.  Sodium-Lithium Countertransport Activity and Insulin Resistance in Normotensive IDDM Patients , 1992, Diabetes.

[5]  R. Krauss,et al.  Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. , 1992, Atherosclerosis.

[6]  A. Semplicini,et al.  Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport. , 1992, Kidney international.

[7]  K. Earle,et al.  Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. , 1992, The New England journal of medicine.

[8]  R. Krauss,et al.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Avogaro,et al.  Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. , 1991, The American journal of physiology.

[10]  S. Haffner,et al.  Dyslipidemia in type II Diabetes: Implications for Therapeutic Intervention , 1991, Diabetes Care.

[11]  H. Lithell,et al.  Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  J. Selby,et al.  Concordance for dyslipidemic hypertension in male twins. , 1991, JAMA.

[13]  A. Quyyumi,et al.  Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. , 1990, The New England journal of medicine.

[14]  A. Semplicini,et al.  Sodium-lithium countertransport in microalbuminuric insulin-dependent diabetic patients. , 1990, Hypertension.

[15]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[16]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[17]  A. Schmitz,et al.  Comparative renal pathophysiology relevant to IDDM and NIDDM patients. , 1988, Diabetes/metabolism reviews.

[18]  S. Hunt,et al.  Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. , 1988, JAMA.

[19]  C Cobelli,et al.  Models to interpret kinetic data in stable isotope tracer studies. , 1987, American Journal of Physiology.

[20]  R N Bergman,et al.  Estimation of Endogenous Glucose Production During Hyperinsulinemic-Euglycemic Glucose Clamps: Comparison of Unlabeled and Labeled Exogenous Glucose Infusates , 1987, Diabetes.

[21]  M. Laakso,et al.  Diabetes and atherosclerosis: an epidemiologic view. , 1987, Diabetes/metabolism reviews.

[22]  D. Taylor-Robinson,et al.  Conventional tissue culture compared with rapid immunofluorescence for identifying chlamydia trachomatis in specimens from patients attending a genitourinary clinic. , 1986, Genitourinary medicine.

[23]  R. Ross The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[24]  J. Brunzell,et al.  Obesity and common genetic metabolic disorders. , 1985, Annals of internal medicine.

[25]  F. Kahl,et al.  Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. , 1985, Journal of lipid research.

[26]  J. Westgard,et al.  Evaluation of the adaptation of the glucose oxidase-peroxidase-3-methyl-2-benzothiazolinone hydrazone-N,N-dimethylaniline procedure to the Technicon "SMA 12-60," and comparison with other automated methods for glucose. , 1974, Clinical chemistry.

[27]  K. Mashimo,et al.  A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients , 1973, Diabetes.

[28]  H. Keen,et al.  AN IMMUNOASSAY METHOD FOR URINARY ALBUMIN AT LOW CONCENTRATIONS. , 1963, Lancet.

[29]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[30]  R. Krauss,et al.  Nondenaturing polyacrylamide gradient gel electrophoresis. , 1986, Methods in enzymology.

[31]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[32]  P. Röschlau,et al.  Enzymatische Bestimmung des Gesamt-Cholesterins im Serum , 1974 .

[33]  A. Wahlefeld Triglycerides Determination after Enzymatic Hydrolysis , 1974 .